Keywords: GA, granuloma annulare; HLP, hypertrophic lichen planus; PD-1, programmed cell death protein-1; SCC, squamous cell carcinoma; checkpoint inhibitors; granuloma annulare; hypertrophic lichen planus; pembrolizumab; programmed cell death protein 1; squamous cell carcinoma.